3 completed. 3 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
| Phase 2 | 3 | Completed 3 |
Follow Hearing Loss, Hidden: new trials by email Literature Review of Hearing Loss, Hidden trials Research Report on Hearing Loss, Hidden
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 1b/2a, Study Evaluating the Safety, PK/PD and Efficacy of NS101 in Healthy Volunteers and SSNHL Patients NS101, Placebo - Seneorineural Deafness, Sudden Sensorineural Hearing Loss | Phase 1 / Phase 2 | Completed | Neuracle Science Co., LTD. | 113 | 2024-02-15 | 2026-11-02 |
| Phase I/IIa Study Evaluating Safety and Efficacy of an Intratympanic Dose of PIPE-505 in Subjects With Hearing Loss PIPE-505, Placebo - Sensorineural Hearing Loss | Phase 1 / Phase 2 | Completed | Contineum Therapeutics | 28 | 2020-10-15 | 2025-04-01 |
| OTO-413 in Subjects With Speech-in-Noise Hearing Impairment OTO-413, Placebo - Sensorineural Hearing Loss | Phase 1 / Phase 2 | Completed | Otonomy, Inc. | 110 | 2019-10-01 | 2022-10-27 |
Hearing Loss, Sensorineural (3) · Hearing Loss (2) · Deafness (1) · Hearing Loss, Sudden (1)
Ear Diseases (3) · Hearing Disorders (3) · Nervous System Diseases (3) · Neurologic Manifestations (3) · Otorhinolaryngologic Diseases (3) · Pathological Conditions, Signs and Symptoms (3) · Sensation Disorders (3) · Signs and Symptoms (3) · Hearing Loss (1)
Contineum Therapeutics (1) · Neuracle Science Co., LTD. (1) · Otonomy, Inc. (1)
United States (2) · South Korea (1)
Joseph Park, M.D. (1) · Stephen Huhn, MD (1)